SHA:603567 Revenue

Heilongjiang ZBD Pharmaceutical had revenue of 204.78M CNY in the quarter ending September 30, 2025, a decrease of -44.14%. This brings the company's revenue in the last twelve months to 1.59B, down -48.84% year-over-year. In the year 2024, Heilongjiang ZBD Pharmaceutical had annual revenue of 2.70B, down -13.84%.

Revenue (ttm)

1.59B

Revenue Growth

-48.84%

P/S Ratio

4.78

Revenue / Employee

678.98K

Employees

2,349

Market Cap

7.62B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.70B	-434.25M	-13.84%
Dec 31, 2023	3.14B	-1.08B	-25.53%
Dec 31, 2022	4.21B	87.33M	2.12%
Dec 31, 2021	4.13B	723.07M	21.24%
Dec 31, 2020	3.40B	111.89M	3.40%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Jan 1, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Northeast Pharmaceutical Group	6.85B
China Animal Husbandry Industry	6.28B
Cisen Pharmaceutical	3.56B
Hunan Jiudian Pharmaceutical	3.05B
Shandong Wit Dyne Health	2.36B
Guangxi Wuzhou Zhongheng Group	2.29B
HARBIN GLORIA PHARMACEUTICALS Co., LTD	2.25B
Jiuzhitang	1.94B

Revenue Rankings